Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Show all 362 references

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Items 701–800 of 1,006

Immune re-education following autologous hematopoietic stem cell transplantation
Abrahamsson, S., & Muraro, P. A. (2008) · Autoimmunity · doi:10.1080/08916930802197081 · Cited by 46
Promiscuous drugs as therapeutics for chemokine receptors
Horuk, R. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000921 · Cited by 48
Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis
Hecker, M., Lorenz, P., Steinbeck, F., Li, H., Riemekasten, G., Li, Y., Zettl, U. K., & Thiesen, H. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.010 · Cited by 45
Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring
Zager, A., Peron, J. P. S., Mennecier, G., Rodrigues, S. C., Aloia, T. P. A., & Palermo‐Neto, J. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.07.021 · Cited by 45
Neonatal Maternal Separation Alters Immune, Endocrine, and Behavioral Responses to Acute Theiler’s Virus Infection in Adult Mice
Meagher, M. W., Sieve, A. N., Johnson, R. R., Satterlee, D. M., Belyavskyi, M., Mi, W., Prentice, T. W., Welsh, T. H., & Welsh, C. J. (2010) · Behavior Genetics · doi:10.1007/s10519-010-9333-5 · Cited by 46
Multiple sclerosis associates with LILRA3 deletion in Spanish patients
Ordóñez, D., Sánchez, A., Rodríguez, J., Cisneros, E., Ramil, E., Romo, N., Moraru, M., Munteis, E., López‐Botet, M., Roquer, J., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.34 · Cited by 45
Potential Triggers of MS
Libbey, J. E., & Fujinami, R. S. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2008_12 · Cited by 45
Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
Li, Z.-H., Wang, Y., He, D., Zhang, X., Zhou, Y., Yue, H., Huang, S., Fu, Z., Zhang, L., Mao, Z., et al. (2019) · Aging · doi:10.18632/aging.102093 · Cited by 45
Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
Enders, M., Heider, T., Ludwig, A., & Küerten, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051663 · Cited by 45
Evidence for humoral autoimmunity in neuromyelitis optica
Wingerchuk, D. M. (2006) · Neurological Research · doi:10.1179/016164106x98260 · Cited by 45
Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro
DaSilva, A. G., & Yong, V. W. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.034 · Cited by 45
Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2
Ji, Z., Fan, Z., Zhang, Y., Yu, R., Yang, H., Zhou, C., Luo, J., & Ke, Z. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302702 · Cited by 45
Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects
Olejnik, P., Roszkowska, Z., Adamus, S., & Kasarełło, K. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00642-0 · Cited by 49
Exposure to IL-15 and IL-21 Enables Autoreactive CD8 T Cells To Respond to Weak Antigens and Cause Disease in a Mouse Model of Autoimmune Diabetes
Ramanathan, S., Dubois, S., Chen, X.-L., LeBlanc, C., Ohashi, P. S., & Ilangumaran, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001221 · Cited by 45
Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study
Kumar, A., Cocco, E. E., Atzori, L., Marrosu, M. G., & Pieroni, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059711 · Cited by 44
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes
Camperio, C., Muscolini, M., Volpe, E., Mitri, D. D., Mechelli, R., Buscarinu, M. C., Ruggieri, S., Piccolella, E., Salvetti, M., Gasperini, C., et al. (2014) · Immunology Letters · doi:10.1016/j.imlet.2013.12.020 · Cited by 46
Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Galal, A. M., Slade, D., Gul, W., El‐Alfy, A. T., Ferreira, D., & ElSohly, M. A. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909788453031 · Cited by 44
The natalizumab wearing-off effect
van Kempen, Z. L. E., Doesburg, D., Dekker, I., Lissenberg-Witte, B. I., de Vries, A., Claessen, I., ten Brinke, A., Rispens, T., & Killestein, J. (2019) · Neurology · doi:10.1212/wnl.0000000000008357 · Cited by 45
Immunopathogenesis of Multiple Sclerosis
Hemmer, B., Töpfner, N., & Hartung, H. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50020-7 · Cited by 44
Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
Berger, T., & Reindl, M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.070 · Cited by 44
γδ T cells in EAE: Early trafficking events and cytokine requirements
Wohler, J. E., Smith, S. S., Zinn, K. R., Bullard, D., & Barnum, S. R. (2009) · European Journal of Immunology · doi:10.1002/eji.200839176 · Cited by 44
Antibody response in MOG35–55 induced EAE
Lalive, P. H., Molnarfi, N., Benkhoucha, M., Weber, M. S., & Santiago‐Raber, M. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.09.005 · Cited by 43
Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens
Venken, K., Hellings, N., Hensen, K., Rummens, J., & Stinissen, P. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.025 · Cited by 43
Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis
Martín-Saavedra, F. M., Flores, N., Dorado, B., Eguiluz, C., Bravo, B., García‐Merino, A., & Ballester, S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.03.002 · Cited by 43
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis
Pennisi, M. A., Rajput, A.-M., Toldo, L., & Pappalardo, F. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s16-s9 · Cited by 43
Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis
Borràs, E., Cantó, E., Choi, M., Villar, L. M., Alvarez-Cermeño, J. C., Chiva, C., Montalbán, X., Vitek, O., Comabella, M., & Sabidó, E. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053256 · Cited by 44
Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases
Ahmadi, M., Gharibi, T., Dolati, S., Rostamzadeh, D., Aslani, S., Baradaran, B., Younesi, V., & Yousefi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.072 · Cited by 44
Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis
Kiasalari, Z., Afshin‐Majd, S., Baluchnejadmojarad, T., Azadi-Ahmadabadi, E., Esmaeil-Jamaat, E., Fahanik‐Babaei, J., Fakour, M., Fereidouni, F., Ghasemi-Tarie, R., Jalalzade-Ogvar, S., et al. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101891 · Cited by 43
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients
Sánchez, A., Román-Vega, L., Ramil, E., Giuffrida, A., & Garcı́a-Merino, A. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12443 · Cited by 43
Variations of the perforin gene in patients with multiple sclerosis
Cappellano, G., Orilieri, E., Comi, C., Chiocchetti, A., Bocca, S., Boggio, E. M., Bernardone, I. S., Cometa, A. M., Clementi, R., Barizzone, N., et al. (2008) · Genes and Immunity · doi:10.1038/gene.2008.35 · Cited by 43
Immune modulating peptides for the treatment and suppression of multiple sclerosis
Badawi, A. H., & Siahaan, T. J. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.05.010 · Cited by 43
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
Linker, R. A., & Lee, D.-H. (2009) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-1-5 · Cited by 43
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment
Hecker, M., Goertsches, R. H., Fatum, C., Koczan, D., Thiesen, H., Guthke, R., & Zettl, U. K. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.77 · Cited by 43
Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients
Rinaldi, L. (2006) · Brain · doi:10.1093/brain/awl179 · Cited by 43
New developments in understanding and treating neuroinflammation
Infante‐Duarte, C., Waiczies, S., Wuerfel, J. T., & Zipp, F. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0292-0 · Cited by 43
Inhibition by Mitoxantrone of In Vitro Migration of Immunocompetent Cells
Kopadze, T., Dehmel, T., Hartung, H.-P., Stüve, O., & Kieseier, B. C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1572 · Cited by 43
PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective
Li, H., Zheng, C., Han, J., Zhu, J., Liu, S., & Jin, T. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.716747 · Cited by 43
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis
Ward, M. D., Jones, D., & Goldman, M. D. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.920820 · Cited by 42
T‐cell responses after haematopoietic stem cell transplantation for aggressive relapsing–remitting multiple sclerosis
Burman, J., Fransson, M. E., Tötterman, T. H., Fagius, J., Mangsbo, S. M., & Loskog, A. (2013) · Immunology · doi:10.1111/imm.12129 · Cited by 42
New Insights into HLA-G and Inflammatory Diseases
Rizzo, R., Bortolotti, D., Baricordi, O. R., & Fainardi, E. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812803590037 · Cited by 42
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)
Kaushansky, N., Altmann, D. M., David, C. S., Lassmann, H., & Ben‐Nun, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-29 · Cited by 42
The water maze paradigm in experimental studies of chronic cognitive disorders: Theory, protocols, analysis, and inference
Kapadia, M., Xu, J., & Šakić, B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.016 · Cited by 44
SncRNA (microRNA & snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent
Muñoz‐Culla, M., Irizar, H., Sáenz-Cuesta, M., Castillo‐Triviño, T., Osorio-Querejeta, I., Sepúlveda, L., de Munaín, A. L., Olascoaga, J., & Otaegui, D. (2016) · Scientific Reports · doi:10.1038/srep20126 · Cited by 44
The roles of RGMa-neogenin signaling in inflammation and angiogenesis
Fujita, Y., & Yamashita, T. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0037-6 · Cited by 42
Critical Roles of IL-33/ST2 Pathway in Neurological Disorders
Isnadi, M. F. A. R., Chin, V. K., Majid, R. A., Lee, T. Y., Abdullah, M. A., Bello, R. O., Ibraheem, Z. O., & Basir, R. (2018) · Mediators of Inflammation · doi:10.1155/2018/5346413 · Cited by 42
Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier
Sheikh, M. H., Henson, S. M., Loiola, R. A., Mercurio, S., Colamatteo, A., Maniscalco, G. T., Rosa, V. D., McArthur, S., & Solito, E. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01810-8 · Cited by 42
Association of the HLA-DRB1⁎15 allele group and the DRB1⁎1501 and DRB1⁎1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil
Brum, D. G., Barreira, A. A., Louzada‐Júnior, P., Mendes‐Junior, C. T., & Donadi, E. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.06.009 · Cited by 42
Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM
Templeton, S. P., & Perlman, S. M. (2007) · Immunologic Research · doi:10.1007/s12026-007-0079-y · Cited by 43
The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: Implications for multiple sclerosis
Carlson, N. G., Hill, K. E., Tsunoda, I., Fujinami, R. S., & Rose, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.01.008 · Cited by 42
Altered maturation of circulating dendritic cells in primary progressive MS patients
López, C., Comabella, M., Alzayat, H., Tintoré, M., & Montalbán, X. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.010 · Cited by 42
Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers
Ferrandi, C., Richard, F., Tavano, P., Hauben, E., Barbié, V., Gotteland, J., Greco, B. M., Fortunato, M., Mariani, M. F., Furlan, R., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510381258 · Cited by 42
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis
Recks, M. S., Stormanns, E. R., Bader, J., Arnhold, S., Addicks, K., & Küerten, S. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.06.004 · Cited by 42
Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis
Keever-Taylor, C. A., Browning, M. B., Johnson, B., Truitt, R. L., Bredeson, C., Behn, B., & Tsao, A. (2007) · Cytotherapy · doi:10.1080/14653240601145223 · Cited by 42
CD8 T Cell Responses to Myelin Oligodendrocyte Glycoprotein-Derived Peptides in Humanized HLA-A*0201-Transgenic Mice
Mars, L. T., Bauer, J., Gross, D., Bucciarelli, F., Firat, H., Hudrisier, D., Lemonnier, F. A., Kosmatopoulos, K., & Liblau, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5090 · Cited by 42
Haptoglobin deficiency facilitates the development of autoimmune inflammation
Galicia, G., Maes, W., Verbinnen, B., Kasran, A., Bullens, D. M. A., Arredouani, M. S., & Ceuppens, J. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939291 · Cited by 42
The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity
Babić, M., & Romagnani, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01219 · Cited by 33
Daclizumab (anti-CD25) in multiple sclerosis
Pfender, N., & Martinꝉ, R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.015 · Cited by 44
Self-citation
Oral Dysbiosis and Neurodegenerative Diseases: Correlations and Potential Causations
Nicholson, J. S., & Landry, K. S. (2022) · Microorganisms · doi:10.3390/microorganisms10071326 · Cited by 43
Dual role of Response gene to complement-32 in multiple sclerosis
Tegla, C., Cudrici, C. D., Azimzadeh, P. N., Singh, A., Trippe, R., Khan, A. S., Chen, H., Andrian‐Albescu, M., Royal, W., Bever, C. T., et al. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.09.005 · Cited by 41
Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models
Kobayashi, T., Suzuki, T., Kaji, R., Serata, M., Nagata, T., Ando, M., Iizuka, R., Tsujibe, S., Murakami, J., Kiyoshima‐Shibata, J., et al. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.617755 · Cited by 41
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation
Mazzola, M. A., Raheja, R., Murugaiyan, G., Rajabi, H. N., Kumar, D. V., Pertel, T., Regev, K., Griffin, R. L., Aly, L., Kivisäkk, P., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0460-z · Cited by 41
Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis
Gutiérrez-Franco, A., Eixarch, H., Costa, C., Gil, V., Castillo, M., Calvo‐Barreiro, L., Montalbán, X., del Rı́o, J. A., & Espejo, C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0154-2 · Cited by 41
The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice
Higashi, C., Kawaji, A., Tsuda, N., Hayashi, M., Saito, R., Yagishita, Y., Suzuki, T., Uruno, A., Nakamura, M., Nakao, K., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.044 · Cited by 44
Immune-mediated genesis of multiple sclerosis
Cavallo, S. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100039 · Cited by 41
Multiple Functional Targets of the Immunoregulatory Activity of Galectin-1
Cooper, D., Ilarregui, J. M., Pesoa, S., Croci, D. O., Perretti, M., & Rabinovich, G. A. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)80011-4 · Cited by 41
Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35–55-induced experimental autoimmune encephalomyelitis
Küerten, S., Javeri, S., Tary‐Lehmann, M., Lehmann, P., & Angelov, D. N. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.016 · Cited by 41
Experimental Autoimmune Encephalomyelitis Mediated by CD8+ T Cells
Ji, Q., & Goverman, J. M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.017 · Cited by 41
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: A contribution to the current debate on disease pathogenesis
Casaccia‐Bonnefil, P., Pandozy, G., & Mastronardi, F. G. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.012 · Cited by 42
Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis
Greer, J. M., Csurhes, P. A., Muller, D., & Pender, M. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6402 · Cited by 41
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
Prins, M., Dutta, R., Baselmans, B. M. L., Brevé, J. J. P., Bol, J. G. J. M., Deckard, S. A., van der Valk, P., Amor, S., Trapp, B. D., de Vries, H. E., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0098-6 · Cited by 41
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice
Wang, J., Chen, F., Zheng, P., Deng, W., Yuan, J., Peng, B., Wang, R., Liu, W., Zhao, H., Wang, Y.-Q., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.03.024 · Cited by 41
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS
LUBLIN, F. D., Cutter, G., Giovannoni, G., Pace, A., Campbell, N., & Belachew, S. M. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.08.005 · Cited by 41
Nuclear Receptors, Inflammation, and Neurodegenerative Diseases
Saijo, K., Crotti, A., & Glass, C. K. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06002-5 · Cited by 42
The chemokine receptor antagonist, TAK‐779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function
Ni, J., Zhu, Y., Zhong, X., Ding, Y. J., Hou, L., Tong, X., Tang, W., Ono, S., Yang, Y., & Zuo, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00528.x · Cited by 40
Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models
So, K., Haraguchi, K., Asakura, K., Isami, K., Sakimoto, S., Shirakawa, H., Mori, Y., Nakagawa, T., & Kaneko, S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2014.10.003 · Cited by 40
Current concepts of the cellular and molecular pathophysiology of multiple sclerosis
Greenstein, J. I. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20387 · Cited by 41
Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-γ signaling in a murine model of inflammatory bowel disease
Sun, Y., Wu, X., Ye, Y., Gong, F., Shen, Y., Cai, T., Zhou, X., Wu, X., & Xu, Q. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.014 · Cited by 40
Cathepsin S dominates autoantigen processing in human thymic dendritic cells
Stoeckle, C., Quecke, P., Rückrich, T., Burster, T., Reich, M., Weber, E., Kalbacher, H., Driessen, C., Melms, A., & Tolosa, E. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.02.003 · Cited by 42
Th1-, Th2-, and Th17-Related Cytokine and Chemokine Receptor mRNA and Protein Expression in the Brain Tissues, T Cells, and Macrophages of Dogs With Necrotizing and Granulomatous Meningoencephalitis
Park, E.-S., Uchida, K., & Nakayama, H. (2013) · Veterinary Pathology · doi:10.1177/0300985813488957 · Cited by 46
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis
Bakshi, R., Yeste, A., Patel, B., Tauhid, S., Tummala, S., Rahbari, R., Chu, R., Regev, K., Kivisäkk, P., Weiner, H. L., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000200 · Cited by 40
Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Manogaran, P., Hanson, J., Olbert, E., Egger, C., Wicki, C. A., Gerth‐Kahlert, C., Landau, K., & Schippling, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111894 · Cited by 41
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis
González‐García, C., Moreno‐Torres, I., García-Hernández, R., Campos-Ruíz, L., Rodríguez‐Esparragoza, L., Coronado, M. J., Grande, A. G., García‐Merino, A., & Sánchez, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.017 · Cited by 40
Simvastatin inhibits secretion of T h17‐polarizing cytokines and antigen presentation by DC s in patients with relapsing remitting multiple sclerosis
Zhang, X., Tao, Y., Wang, J., García‐Mata, R., & Markovic‐Plese, S. (2012) · European Journal of Immunology · doi:10.1002/eji.201242566 · Cited by 40
Liver X receptors, nervous system, and lipid metabolism.
Cermenati, G., Brioschi, E., Abbiati, F., Melcangi, R. C., Caruso, D., & Mitro, N. (2013) · PubMed · doi:10.3275/8941 · Cited by 42
Interleukin-7 is required for CD4 + T cell activation and autoimmune neuroinflammation
Lawson, B. R., González‐Quintial, R., Eleftheriadis, T., Farrar, M. A., Miller, S. D., Sauer, K., McGavern, D. B., Kono, D. H., Baccalà, R., & Theofilopoulos, A. N. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.08.007 · Cited by 41
ICOS Deficiency Results in Exacerbated IL-17 Mediated Experimental Autoimmune Encephalomyelitis
Galicia, G., Kasran, A., Uyttenhove, C., Swert, K. D., Snick, J. V., & Ceuppens, J. L. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9287-7 · Cited by 40
Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
Carlson, N. G., Rojas, M. A., Redd, J. W., Tang, P., Wood, B., Hill, K. E., & ROSE, J. W. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-25 · Cited by 40
The LPS Receptor, CD14 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Walter, S., Döring, A., Letièmbre, M., Liu, Y., Hao, W., Diem, R., Bernreuther, C., Glatzel, M., Engelhardt, B., & Fassbender, K. C. (2006) · Cellular Physiology and Biochemistry · doi:10.1159/000092078 · Cited by 40
Drug Insight: using monoclonal antibodies to treat multiple sclerosis
Hohlfeld, R., & Wekerle, H. (2005) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0016 · Cited by 41
Charge Isomers of Myelin Basic Protein: Structure and Interactions with Membranes, Nucleotide Analogues, and Calmodulin
Wang, C., Neugebauer, U., Bürck, J., Myllykoski, M., Baumgärtel, P., Popp, J., & Kursula, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019915 · Cited by 42
Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid
Hestvik, A. L. K., Skorstad, G., Price, D. A., Vartdal, F., & Holmøy, T. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508089411 · Cited by 40
A Pathogenic Role for CD8+ T Cells in a Spontaneous Model of Demyelinating Disease
Brisebois, M., Zehntner, S. P., Estrada, J. A., Owens, T., & Fournier, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2403 · Cited by 40
Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice – A step towards understanding the complexity of multiple sclerosis
Kuerten, S., & Angelov, D. N. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2007.11.001 · Cited by 40
Euphol prevents experimental autoimmune encephalomyelitis in mice: Evidence for the underlying mechanisms
Dutra, R. C., de Souza, P. R. D. C., Bento, A. F., Marcon, R., Bicca, M. A., Pianowski, L. F., & Calixto, J. Β. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.026 · Cited by 39
Neuronal IκB Kinase β Protects Mice from Autoimmune Encephalomyelitis by Mediating Neuroprotective and Immunosuppressive Effects in the Central Nervous System
Emmanouil, M., Taoufik, E., Tseveleki, V., Vamvakas, S. M., Tselios, T. V., Karin, M., Lassmann, H., & Probert, L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900834 · Cited by 39
Potent and Orally Efficacious Bisthiazole-Based Histone Deacetylase Inhibitors
Chen, F., Chai, H., Su, M., Zhang, Y., Li, J. X., Xie, X., & Nan, F. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400470s · Cited by 40
The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation
Zozulya, A. L., & Wiendl, H. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.07.014 · Cited by 39
The Role of Kinin Receptors in Preventing Neuroinflammation and Its Clinical Severity during Experimental Autoimmune Encephalomyelitis in Mice
Dutra, R. C., Leite, D. F. P., Bento, A. F., Manjavachi, M. N., Patrício, E. D. S., Figueiredo, C. P., Pesquero, J. B., & Calixto, J. Β. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027875 · Cited by 39
Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design
Gutiérrez-Franco, A., Costa, C., Eixarch, H., Castillo, M., Medina-Rodriguez, E. M., Bribián, A., de Castro, F., Montalbán, X., & Espejo, C. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.12.005 · Cited by 39
Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis
Ramasamy, R., Joseph, B., & Whittall, T. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.003 · Cited by 39

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks